GlassScriptPhysician profile
John T Culhane
NPI 1821105628
$1,753.33
in general payments reported to CMS, 2019-2025
16 companies · $212 in 2025
The $212 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $483 · 2020: $347 · 2021: $15.98 · 2022: $190 · 2023: $168 · 2024: $337 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $717.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $717.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $337.61 | 2019-2023 | Activ.A.C., V.A.C. Dermatac |
| Davol INC. | $275.17 | 2019-2020 | |
| Cook Medical LLC | $240.45 | 2024-2025 | Cook, Zenith Alpha |
| Acell, INC. | $219.52 | 2019 | |
| Intuitive Surgical, INC. | $158.57 | 2022 | |
| Penumbra, INC. | $145.49 | 2024 | Indigo System |
| W. L. Gore & Associates, INC. | $99.80 | 2021-2024 | Gore Enform Preperitoneal Biomaterial, Gore Synecor Biomaterial |
| Kerecis Limited | $67.46 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Ethicon US, LLC | $61.14 | 2020-2024 | Monocryl, Enseal, Harmonic |
| Integra Lifesciences Corporation | $27.70 | 2023 | Integra, Surgimend, Omnigraft |
| Dilon Technologies, INC. | $27.54 | 2025 | Hemoblast Bellows |
| Avita Medical Americas, LLC | $24.89 | 2025 | Recell, Cohealyx, Permeaderm |
| Solventum Corporation | $19.60 | 2024 | V.A.C.Ulta, V.A.C. Veraflo, Prevena |
| E.R. Squibb & Sons, L.L.C. | $19.21 | 2022 | |
| Atricure, INC. | $17.43 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $11.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Culhane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.